ConvaTec Group Plc (CNVVY)
USD 13.29
(8.92%)
USD 13.29
(8.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 872.5 Million USD | 0.69% |
| 2022 | 882.8 Million USD | -3.99% |
| 2021 | 919.5 Million USD | 13.83% |
| 2020 | 807.8 Million USD | -5.93% |
| 2019 | 858.7 Million USD | 21.61% |
| 2018 | 706.1 Million USD | 4.07% |
| 2017 | 678.5 Million USD | -4.88% |
| 2016 | 713.3 Million USD | 15.03% |
| 2015 | 620.1 Million USD | -9.96% |
| 2014 | 688.7 Million USD | 8.05% |
| 2013 | 637.4 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 240.55 Million USD | -44.39% |
| 2024 Q2 | 237.5 Million USD | -1.27% |
| 2023 Q4 | 432.53 Million USD | 79.29% |
| 2023 Q3 | 241.25 Million USD | -46.67% |
| 2023 Q2 | 452.4 Million USD | 85.07% |
| 2023 FY | 888.9 Million USD | 0.69% |
| 2023 Q1 | 244.45 Million USD | -45.28% |
| 2022 Q3 | 248.7 Million USD | -42.81% |
| 2022 Q2 | 434.9 Million USD | 75.89% |
| 2022 FY | 882.8 Million USD | -3.99% |
| 2022 Q1 | 247.25 Million USD | -48.87% |
| 2022 Q4 | 446.75 Million USD | 79.63% |
| 2021 Q3 | 256.75 Million USD | -36.51% |
| 2021 FY | 919.5 Million USD | 13.83% |
| 2021 Q4 | 483.55 Million USD | 88.34% |
| 2021 Q2 | 404.4 Million USD | 90.93% |
| 2021 Q1 | 211.8 Million USD | -46.59% |
| 2020 Q2 | 362.8 Million USD | 89.06% |
| 2020 Q3 | 209.7 Million USD | -42.2% |
| 2020 Q4 | 396.56 Million USD | 89.11% |
| 2020 Q1 | 191.9 Million USD | -48.02% |
| 2020 FY | 807.8 Million USD | -5.93% |
| 2019 Q2 | 355.7 Million USD | 94.48% |
| 2019 Q1 | 182.89 Million USD | 2.93% |
| 2019 Q3 | 257.5 Million USD | -27.61% |
| 2019 FY | 858.7 Million USD | 21.61% |
| 2019 Q4 | 369.19 Million USD | 43.38% |
| 2018 FY | 706.1 Million USD | 4.07% |
| 2018 Q4 | 177.7 Million USD | 0.0% |
| 2018 Q3 | 177.7 Million USD | -1.69% |
| 2018 Q2 | 180.75 Million USD | 0.0% |
| 2018 Q1 | 180.75 Million USD | -0.25% |
| 2017 Q1 | 181.14 Million USD | -19.56% |
| 2017 Q2 | 181.14 Million USD | 0.0% |
| 2017 Q3 | 181.2 Million USD | 0.03% |
| 2017 Q4 | 181.2 Million USD | 0.0% |
| 2017 FY | 678.5 Million USD | -4.88% |
| 2016 Q1 | 132.1 Million USD | -32.53% |
| 2016 Q4 | 225.2 Million USD | 0.0% |
| 2016 Q2 | 202.6 Million USD | 53.37% |
| 2016 Q3 | 225.2 Million USD | 11.15% |
| 2016 FY | 713.3 Million USD | 15.03% |
| 2015 Q2 | 181 Million USD | 3.61% |
| 2015 Q4 | 195.8 Million USD | 44.61% |
| 2015 FY | 620.1 Million USD | -9.96% |
| 2015 Q1 | 174.7 Million USD | -24.14% |
| 2015 Q3 | 135.4 Million USD | -25.19% |
| 2014 Q1 | 163.39 Million USD | -13.22% |
| 2014 Q3 | 158.5 Million USD | -6.82% |
| 2014 Q4 | 230.3 Million USD | 45.3% |
| 2014 FY | 688.7 Million USD | 8.05% |
| 2014 Q2 | 170.1 Million USD | 4.1% |
| 2013 Q2 | 155.1 Million USD | 14.72% |
| 2013 FY | 637.4 Million USD | 0.0% |
| 2013 Q1 | 135.2 Million USD | 0.0% |
| 2013 Q3 | 161.8 Million USD | 4.32% |
| 2013 Q4 | 188.3 Million USD | 16.38% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -30371.546% |
| Ansell Limited | 495.5 Million USD | -76.085% |
| Ansell Limited | 495.5 Million USD | -76.085% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -953.696% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -50311.496% |
| Psykey, Inc. | 1.21 Million USD | -71800.649% |
| ConvaTec Group Plc | 910.31 Million USD | 4.154% |
| Encision Inc. | 3.77 Million USD | -23001.904% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -615155.516% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -793579.672% |
| Innovative MedTech Inc. | 6.09 Million USD | -14205.622% |
| LifePoint, Inc. | 7.42 Million USD | -11652.63% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -13642.322% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -101946.784% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -120056.886% |
| Reflect Scientific, Inc. | 1.06 Million USD | -81925.084% |
| SmileDirectClub, Inc. | 517 Million USD | -68.761% |
| Sector 10, Inc. | 39.84 Thousand USD | -2189690.182% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 86.866% |
| SheerVision, Inc. | 2.33 Million USD | -37320.094% |
| United Health Products, Inc. | 2.42 Million USD | -35856.562% |
| Vasamed, Inc. | 4.67 Million USD | -18571.433% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -33958.031% |
| Yubo International Biotech Limited | 1.25 Million USD | -69263.013% |